Taichu (Shenzhen) Biotechnology Co., Ltd. was founded in 2022 as a key part of the Taichu Group, playing a crucial role in the group's business strategy. It provides various consulting services including the R&D of antibody drugs, non-clinical pharmacology/toxicology studies, CMC, GMP manufacturing and IND registration. Taichu (Shenzhen) can also holdes academic communication events and business activities.